YEAR 2020.
Molecularevaluation of HIF-1a gene variation and determination of its frequency, andassociation with Breast Cancer susceptibility in Saudi Arabia.
Mir R,Abu-Duhier FM, Albalawi IA. Endocr Metab Immune Disord Drug Targets. 2020 Sep9.
Correction to: Ectopic PD-L1expression in JAK2 (V617F) myeloproliferative neoplasm patients is mediated viaincreased activation of STAT3 and STAT5.
GuruSA, Sumi MP, Mir R, Waza AA, Bhat MA, Zuberi M, Lali P, Saxena A. HumCell. 2020 Jul 14.
Natural Killer Cells Expanded andPreactivated Exhibit Enhanced Antitumor Activity against Different Tumor Cellsin Vitro.
BiswasBK, Guru SA, Sumi MP, Jamatia E, Gupta RK, Lali P, Konar BC, Saxena A, MirR. Asian Pac J Cancer Prev. 2020 Jun 1;21(6):1595-1605. doi:10.31557/APJCP.2020.21.6.1595.
Ectopic PD-L1 expression in JAK2(V617F) myeloproliferative neoplasm patients is mediated via increasedactivation of STAT3 and STAT5.
GuruSA, Sumi MP, Mir R, Waza AA, Bhat MA, Zuberi M, Lali P, Saxena A. HumCell. 2020 Jul 14. doi: 10.1007/s13577-020-00370-6.
Role of non-coding RNA networks inleukemia progression, metastasis and drug resistance.
BhatAA, Younes SN, Raza SS, Zarif L, Nisar S, Ahmed I, Mir R, Kumar S, SharawatSK, Hashem S, Elfaki I, Kulinski M, Kuttikrishnan S, Prabhu KS, Khan AQ, YadavSK, El-Rifai W, Zargar MA, Zayed H, Haris M, Uddin S. Mol Cancer. 2020 Mar12;19(1):57.
Genetic Effects of VascularEndothelial Growth Factor A (VEGF-A) and Its Association with DiseaseProgression in Breast Cancer Population of Saudi Arabia.
AlbalawiIA, Mir R, Abu Duhier FM. Asian Pac J Cancer Prev. 2020 Jan1;21(1):139-145.
YEAR 2019.
2: Elfaki I, Mir R, Mir MM, AbuDuhier FM, Babakr AT, BarnawiJ. Potential Impact
of MicroRNA Gene Polymorphisms in the Pathogenesis ofDiabetes and
Atherosclerotic Cardiovascular Disease. J Pers Med. 2019 Nov25;9(4). pii: E51.
doi: 10.3390/jpm9040051. Review. PubMed PMID: 31775219.
3: Albalawi IA, Mir R, Abu-Duhier FM. Molecular evaluationof PROGINS mutation in
Progesterone Receptor gene and determination of itsfrequency, distribution
pattern and association with Breast Cancer susceptibility inSaudi Arabia. Endocr
Metab Immune Disord Drug Targets. 2019 Nov 25. doi:
10.2174/1871530319666191125153050. [Epub ahead of print]PubMed PMID: 31763970.
4: Elfaki I, Mir R, Abu-Duhier FM, Khan R, Sakran M.Phosphatidylinositol
3-kinase Glu545Lys and His1047Tyr Mutations are notAssociated with T2D. Curr
Diabetes Rev. 2019 Oct 15. doi:10.2174/1573399815666191015142201. [Epub ahead of
print] PubMed PMID: 31749428.
5: Jha CK, Mir R, Banu S, Elfaki I, Chahal SMS. Heterozosityin LDLR rs2228671
and LDLR rs72658855 are associated with increased risk ofdeveloping Coronary
artery disease in India -A case control study. Endocr MetabImmune Disord Drug
Targets. 2019 Oct 15. doi:10.2174/1871530319666191015164505. [Epub ahead of
print] PubMed PMID: 31613733.
6: K Jha C, Mir R, Elfaki I, Banu S, Chahal SMS. LDLR GenePolymorphisms (rs5925
and rs1529729) Are Associated with Susceptibility toCoronary Artery Disease in a
South Indian Population. Med Sci (Basel). 2019 Jul 15;7(7).pii: E80. doi:
10.3390/medsci7070080. PubMed PMID: 31311124; PubMed CentralPMCID: PMC6681362.
7: Jha CK, Mir R, Elfaki I, Javid J, Babakr AT, Banu S,Chahal SMS. Evaluation of
the Association of Omentin 1 rs2274907 A>T and rs2274908G>A Gene Polymorphisms
with Coronary Artery Disease in Indian Population: A CaseControl Study. J Pers
Med. 2019 Jun 6;9(2). pii: E30. doi: 10.3390/jpm9020030.PubMed PMID: 31174318;
PubMed Central PMCID: PMC6617120.
8: Sumi MP, Guru SA, Mir R, Masroor M, Bhat MA, Girish MP,Saxena A. Clinical
Importance of Estrogen Receptor 1 (ESR1) Gene Polymorphismsand Their Expression
Patterns in Coronary Artery Disease Patients: A Study fromIndia. Indian J Clin
Biochem. 2019 Apr;34(2):133-142. doi:10.1007/s12291-019-00827-y. Epub 2019 Apr
5. PubMed PMID: 31092986; PubMed Central PMCID: PMC6486943.
9: Mir R, Jha CK, Elfaki I, Javid J, Rehman S, Khullar N,Banu S, Chahal SMS.
Incidence of MicroR-4513C/T Gene Variability in CoronaryArtery Disease - A
Case-Control Study. Endocr Metab Immune Disord Drug Targets.
2019;19(8):1216-1223. doi:10.2174/1871530319666190417111940. PubMed PMID:
31038082.
10: Zuberi M, Mir R, Khan I, Javid J, Guru SA, Bhat M, SumiMP, Ahmad I, Masroor
M, Yadav P, Vishnubhatla S, Saxena A. The promisingsignatures of circulating
microRNA-145 in epithelial ovarian cancer patients.Microrna. 2019 Feb 24. doi:
10.2174/2211536608666190225111234. [Epub ahead of print]PubMed PMID: 30799804.
11: Mir R, Jha CK, Elfaki I, Rehman S, Javid J, Khullar N,Banu S, Chahal SMS.
MicroRNA-224 (rs188519172 A>G) Gene Variability isAssociated with a Decreased
Susceptibility to Coronary Artery Disease: A Case-ControlStudy. Microrna.
2019;8(3):198-205. doi: 10.2174/2211536608666181211153859.PubMed PMID: 30539710.
12: Jha CK, Mir R, Elfaki I, Khullar N, Rehman S, Javid J,Banu S, Chahal SMS.
Potential Impact of MicroRNA-423 Gene Variability inCoronary Artery Disease.
Endocr Metab Immune Disord Drug Targets. 2019;19(1):67-74.doi:
10.2174/1871530318666181005095724. PubMed PMID: 30289085.
YEAR 2018.
13: Abu-Duhier FM, Javid J, Sughayer MA, Mir R, Albalawi T,Alauddin MS. Clinical
Significance of Circulatory miRNA-21 as an EfficientNon-Invasive Biomarker for
the Screening of Lung Cancer Patients. Asian Pac J CancerPrev. 2018 Sep
26;19(9):2607-2611. PubMed PMID: 30256067; PubMed CentralPMCID: PMC6249464.
14: Elfaki I, Mir R, Almutairi FM, Duhier FMA. CytochromeP450: Polymorphisms and
Roles in Cancer, Diabetes and Atherosclerosis. Asian Pac JCancer Prev. 2018 Aug
24;19(8):2057-2070. Review. PubMed PMID: 30139042; PubMedCentral PMCID:
PMC6171375.
15: Mir R, Bhat M, Javid J, Jha C, Saxena A, Banu S.Potential Impact of
COMT-rs4680 G > A Gene Polymorphism in Coronary ArteryDisease. J Cardiovasc Dev
Dis. 2018 Jul 13;5(3). pii: E38. doi: 10.3390/jcdd5030038.PubMed PMID: 30011860;
PubMed Central PMCID: PMC6162781.
16: Jha CK, Mir R, Khullar N, Banu S, Chahal SMS. LDLR rs688TT Genotype and T
Allele Are Associated with Increased Susceptibility toCoronary Artery Disease-A
Case-Control Study. J Cardiovasc Dev Dis. 2018 May 29;5(2).pii: E31. doi:
10.3390/jcdd5020031. PubMed PMID: 29843469; PubMed CentralPMCID: PMC6023456.
17: Bhat MA, Guru SA, Mir R, Waza AA, Zuberi M, Sumi MP,Bodeliwala S, Puri V,
Saxena A. Association of GABAA Receptor Gene with EpilepsySyndromes. J Mol
Neurosci. 2018 Jun;65(2):141-153. doi:10.1007/s12031-018-1081-7. Epub 2018 May
21. PubMed PMID: 29785705.
18: Al Balawi IA, Mir R, Abu-Duhier FM. Potential Impact ofVascular Endothelial
Growth Factor Gene Variation (-2578C>A) on Breast CancerSusceptibility in Saudi
Arabia: a Case-Control Study. Asian Pac J Cancer Prev. 2018Apr
27;19(4):1135-1143. PubMed PMID: 29699375; PubMed CentralPMCID: PMC6031782.
19: Mir R, Javid J, Al Balawi IA, Alkharsah KR, Hadi MA,Rahman MA, Hamoud E, Al
Alawi Y, Al Zahrani ABM, Abu-Duhier FM. A Germline Mutationin the BRCA1 3’UTR
Variant Predicts Susceptibility to Breast Cancer in a SaudiArabian Population.
Asian Pac J Cancer Prev. 2018 Mar 27;19(3):859-866. PubMedPMID: 29582646; PubMed
Central PMCID: PMC5980867.
YEAR 2017.
20: Guru SA, Mir R, Bhat M, Najar I, Zuberi M, Sumi M,Masroor M, Gupta N, Saxena
A. PDGFRa promoter polymorphisms and expression patternsinfluence risk of
development of imatinib-induced thrombocytopenia in chronicmyeloid leukemia: A
study from India. Tumour Biol. 2017Oct;39(10):1010428317713857. doi:
10.1177/1010428317713857. PubMed PMID: 29019285.
21: Abu-Duhier F, Mir R. GSTT1 (rs4025935) null genotype isassociated with
increased risk of sickle cell disease in the populations ofTabuk-Northwestern
region of Saudi Arabia. Hematology. 2017 Apr;22(3):172-177.doi:
10.1080/10245332.2016.1201631. Epub 2016 Nov 25. PubMedPMID: 27885941.
22: Mir R, Najar IA, Guru S, Javaid J, Yadav P, Masroor M,Zuberi M, Farooq S,
Bhat M, Gupta N, Ray PC, Saxena A. A deletion polymorphismin the RIZ gene is
associated with increased progression of imatinib treatedchronic myeloid
leukemia patients. Leuk Lymphoma. 2017 Jul;58(7):1694-1701.doi:
10.1080/10428194.2016.1251589. Epub 2016 Nov 10. PubMedPMID: 27830966.
YEAR 2016.
23: Mir R, Masroor M, Javid J, Ahamad I, Farooq S, Yadav P,Zuberi M, Lone M, Ray
PC, Saxena A. Clinical implications of cytosine deletion of exon5 of P53 gene in
non small cell lung cancer patients. South Asian J Cancer.2016
Jan-Mar;5(1):33-6. doi: 10.4103/2278-330X.179701. PubMedPMID: 27169122; PubMed
Central PMCID: PMC4845608.
24: Zuberi M, Khan I, Mir R, Gandhi G, Ray PC, Saxena A.Utility of Serum
miR-125b as a Diagnostic and Prognostic Indicator and ItsAlliance with a Panel
of Tumor Suppressor Genes in Epithelial Ovarian Cancer. PLoSOne. 2016 Apr
19;11(4):e0153902. doi: 10.1371/journal.pone.0153902.eCollection 2016. PubMed
PMID: 27092777; PubMed Central PMCID: PMC4836713.
25: Yadav P, Mir R, Nandi K, Javid J, Masroor M, Ahmad I,Zuberi M, Kaza R, Jain
S, Khurana N, Ray PC, Saxena A. The C609T (Pro187Ser) NullPolymorphism of the
NQO1 Gene Contributes Significantly to Breast CancerSusceptibility in North
Indian Populations: a Case Control Study. Asian Pac J CancerPrev.
2016;17(3):1215-9. PubMed PMID: 27039751.
26: Javid J, Mir R, Saxena A. Involvement of CASP3 promoterpolymorphism (-1337
C?>?G) in the development and progression of non-smallcell lung cancer. Tumour
Biol. 2016 Jul;37(7):9255-62. doi:10.1007/s13277-016-4800-0. Epub 2016 Jan 15.
PubMed PMID: 26768747.
YEAR 2015.
27: Mir R, Ahmad I, Javid J, Zuberi M, Yadav P, Shazia R,Masroor M, Guru S, Ray
PC, Gupta N, Saxena A. Simple multiplex RT-PCR foridentifying common fusion
BCR-ABL transcript types and evaluation of molecularresponse of the a2b2 and
a2b3 transcripts to Imatinib resistance in north Indianchronic myeloid leukemia
patients. Indian J Cancer. 2015 Jul-Sep;52(3):314-8. doi:
10.4103/0019-509X.176741. PubMed PMID: 26905124.
28: Masroor M, Jain A, Javid J, Mir R, Prashant Y, ImtiyazA, Mariyam Z, Mohan A,
Ray PC, Saxena A. Clinical Significance of the NQO1 C609TPolymorphism in Non
Small Cell Lung Adenocarcinoma Patients. Asian Pac J CancerPrev.
2015;16(17):7653-8. PubMed PMID: 26625776.
29: Masroor M, Amit J, Javid J, Mir R, Prasant Y, Imtiyaz A,Mariyam Z, Mohan A,
Ray PC, Saxena A. Clinical Implication of EGF A61G Polymorphismin the Risk of
Non Small Cell Lung Adenocarcinoma Patients: A Case ControlStudy. Asian Pac J
Cancer Prev. 2015;16(17):7529-34. PubMed PMID: 26625757.
30: Masroor M, Mir R, Javid J, Prasant Y, Imtiyaz A, MariyamZ, Mohan A, Ray PC,
Saxena A. Cell Free EGFR mRNA Expression and Implicationsfor Survival and
Metastasis in Non-Small Cell Lung Cancer Cases. Asian Pac JCancer Prev.
2015;16(15):6445-9. PubMed PMID: 26434857.
31: Masroor M, Javid J, Mir R, Y P, A I, Z M, Mohan A, RayPC, Saxena A.
Prognostic significance of serum ERBB3 and ERBB4 mRNA inlung adenocarcinoma
patients. Tumour Biol. 2016 Jan;37(1):857-63. doi:10.1007/s13277-015-3859-3.
Epub 2015 Aug 9. PubMed PMID: 26254096.
32: Amle D, Mir R, Khaneja A, Agarwal S, Ahlawat R, Ray PC,Saxena A. Association
of 18bp insertion/deletion polymorphism, at -2549 positionof VEGF gene, with
diabetic nephropathy in type 2 diabetes mellitus patients ofNorth Indian
population. J Diabetes Metab Disord. 2015 Mar 27;14:19. doi:
10.1186/s40200-015-0144-3. eCollection 2015. PubMed PMID:25909076; PubMed
Central PMCID: PMC4407794.
33: Mir R, Ah I, Javid J, Zuberi M, Guru S, Mirza M, FarooqS, Yadav P, Ray PC,
Gupta N, Saxena A. Polymorphism T81C in H-RAS Oncogene IsAssociated With Disease
Progression in Imatinib (TKI) Treated Chronic MyeloidLeukemia Patients. World J
Oncol. 2015 Apr;6(2):321-328. doi: 10.14740/wjon912e. Epub2015 Apr 12. PubMed
PMID: 29147425; PubMed Central PMCID: PMC5649720.
34: Javid J, Mir R, Julka PK, Ray PC, Saxena A. Role ofsurvivin re-expression in
the development and progression of non-small cell lungcancer. Tumour Biol. 2015
Jul;36(7):5543-50. doi: 10.1007/s13277-015-3224-6. Epub 2015Feb 14. PubMed PMID:
25677909.
35: Javid J, Mir R, Julka PK, Ray PC, Saxena A. Associationof p53 and mdm2 in
the development and progression of non-small cell lungcancer. Tumour Biol. 2015
Jul;36(7):5425-32. doi: 10.1007/s13277-015-3208-6. Epub 2015Feb 12. PubMed PMID:
25672611.
36: Javid J, Mir R, Julka PK, Ray PC, Saxena A.Extracellular cytochrome c as a
biomarker for monitoring therapeutic efficacy and prognosisof non-small cell
lung cancer patients. Tumour Biol. 2015 Jun;36(6):4253-60.doi:
10.1007/s13277-015-3062-6. Epub 2015 Jan 13. PubMed PMID:25578497.
37: Anand H, Mir R, Saxena R. Hemoglobin color scale adiagnostic dilemma. Indian
J Pathol Microbiol. 2009 Jul-Sep;52(3):360-2. doi:10.4103/0377-4929.54994.
PubMed PMID: 19679961.
38: Sazawal S, Kumar B, Hasan SK, Dutta P, Kumar R, ChaubeyR, Mir R, Saxena R.
Haematological & molecular profile of acute myelogenousleukaemia in India.
Indian J Med Res. 2009 Mar;129(3):256-61. PubMed PMID:19491417.
39: Hasan SK, Sazawal S, Kumar B, Chaubey R, Mishra P, MirR, Chaudhry VP, Saxena
R. Childhood CML in India: b2a2 transcript is more commonthan b3a2. Cancer Genet
Cytogenet. 2006 Aug;169(1):76-7. PubMed PMID: 16875942.